High circulating levels of IGF-1 and low levels of IGFBP-3 (a major IGFBP that accounts for ~75% of IGF-1 bound) have been shown to be associated with an increased risk of several types of cancers, including colorectal cancer [20,21]. The gene discussed is IGF1; the disease is cancer.